Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial
Yosuke Aoyama, Kosuke Kashiwabara, Yuichiro Kikawa, Naruto Taira, Hirofumi Mukai, Masato Takahashi
Springer Nature ·
2026-03-30
· DOI 10.1007/s12282-026-01852-5
The publisher did not provide an abstract — full text is available via the link below.
Yosuke Aoyama, Kosuke Kashiwabara, Yuichiro Kikawa, Naruto Taira, Hirofumi Mukai, Masato Takahashi. Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial. // Breast Cancer. – 2026. – DOI: 10.1007/s12282-026-01852-5. – URL: https://doi.org/10.1007/s12282-026-01852-5
Yosuke Aoyama, Kosuke Kashiwabara, Yuichiro Kikawa, Naruto Taira, Hirofumi Mukai, & Masato Takahashi (2026). Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial. Breast Cancer. https://doi.org/10.1007/s12282-026-01852-5
Yosuke Aoyama, et al. “Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.” Breast Cancer, 2026. doi:10.1007/s12282-026-01852-5.
@article{Aoyama2026,
title = {Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial},
author = {Aoyama, Yosuke and Kashiwabara, Kosuke and Kikawa, Yuichiro and Taira, Naruto and Mukai, Hirofumi and Takahashi, Masato},
journal = {Breast Cancer},
year = {2026},
doi = {10.1007/s12282-026-01852-5},
url = {https://doi.org/10.1007/s12282-026-01852-5}
}